Lise Mørkved Helsingen

Image of Lise Mørkved Helsingen
Norwegian version of this page
Username
Visiting address Klinisk Effektforskning Gaustad Sykehus Bygg 20 Sognsvannsveien 21 0372 Oslo
Postal address Postboks 1089 Blindern 0317 Oslo

Academic interests

  • Inflammatory bowel disease and cancer risk
  • Screening for colorectal cancer
  • Epidemiology
  • Registry based research
  • Guideline development
  • Risk stratification and risk perception.

Background

Lise Mørkved Helsingen is a MD and a PhD candidate in the Clinical Effectiveness Research Group at the University of Oslo and Oslo university Hospital.

The academic year of 2018/2019 she is a visiting student researcher at the Harvard T.H. Chan School of Public Health in Boston, USA.

She is a former medical editor at the Journal of The Norwegian Medical Association.

Awards

Fulbright Scholarship 2018.

Publications

View all works in Cristin

  • Øverenget, Einar; Kalager, Mette; Grødeland, Gunnveig; Olsvik, Ørjan; Nylund, Anna & Løberg, Magnus [Show all 8 contributors for this article] (2022). Når smittevern blir uforståelig. Dagensnæringsliv.
  • Bretthauer, Michael; Helsingen, Lise Mørkved; Kalager, Mette; Vandvik, Per Olav; Agoritsas, Thomas & Guyatt, Gordon (2020). The future of colorectal cancer screening: Parentalism or shared decision-making? CMAJ - Canadian Medical Association Journal. ISSN 0820-3946. 192(18). doi: 10.1503/cmaj.74839.
  • Helsingen, Lise M.; Vandvik, Per Olav; Jodal, Henriette C.; Murphy, Silje Bjerkelund; Heen, Anja Fog & Kalager, Mette [Show all 7 contributors for this article] (2019). Tarmkreftscreening, eller ikke? Tidsskrift for Den norske legeforening. ISSN 0029-2001. 139(15). doi: 10.4045/tidsskr.19.0323.
  • Refsum, Erle; Helsingen, Lise M.; Jodal, Henriette Cecilie; Løberg, Magnus; Høstmælingen, Njål & Kalager, Mette (2019). Personvern – en hinderløype. Tidsskrift for Den norske legeforening. ISSN 0029-2001. 139(4), p. 1–3. doi: 10.4045/tidsskr.19.0077.
  • Juul, Frederik Emil; Garborg, Kjetil Kjeldstad; Bretthauer, Michael; Kalager, Mette; Midtvedt, Tore & Furholm, Siv [Show all 17 contributors for this article] (2018). Fecal microbiota transplantation versus antibiotics for primary Clostridium difficile infection - a multicenter, randomized proof-of-concept trial.
  • Kalager, Mette; Hagen, Eirik M. & Helsingen, Lise M. (2016). Farlig forretning på frykt. Dagens næringsliv. ISSN 0803-9372. 127(278), p. 30–30.
  • Helsingen, Lise M. (2015). Ett år som medisinsk redaktør. Tidsskrift for Den norske legeforening. ISSN 0029-2001. 135. doi: 10.4045/tidsskr.15.0851.

View all works in Cristin

Published Feb. 13, 2019 3:54 PM - Last modified Feb. 22, 2019 9:47 AM